Cohance Lifesciences: The financial results for the period ended September 30, 2026
Cohance Lifesciences (COHANCE) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹16,586 crore.
What happened
Cohance Lifesciences (COHANCE) filed a disclosure with the exchanges on 6 November 2026 at 05:48 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Cohance Lifesciences is a small-cap company in the Healthcare sector, with a market value of about ₹16,586 crore.
The stock last traded at ₹433.6, against a 52-week range of ₹266.7–₹744.3 (41.8% below the high).
Before this filing the shares had moved +0.8% over the month and +4.9% over three months. Average daily turnover over the last 20 sessions was about ₹35.7 crore.
Promoters held 57.49% at the end of Q1 FY27; 94.56% of promoter shares were pledged. Foreign institutions owned 6.50% and domestic institutions 20.09%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 549 | 48.9 | 1.28 |
| Q2 FY26 | 1,105 | 123 | 3.22 |
| Q3 FY26 | 545 | 36.7 | 0.96 |
| Q4 FY26 | 619 | 19.6 | 0.51 |
| Q1 FY27 | 422 | -24.1 | -0.63 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.0% over five days; 57% of them rose the next day.
Market-wide, 10,840 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 6 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- COHANCE Stock Price and Chart — NSE:COHANCE
- Cohance Lifesciences: Can a recovery justify its valuation?
- Cohance Lifesciences manufacturing site in Telangana shut after worker dies in accident
- Cohance Lifesciences to Review September Quarter Results on Nov 6
- Cohance Lifesciences plant ordered shut in Telangana after employee dies in industrial accident
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.